Osteopontin mediates glioblastoma-associated macrophage infiltration and is a therapeutic target Michelle Palacino October 11, 2018 News 0 Comments Read more articles Previous Post$50M Barrow Brain Tumor Center Will Seek Cures For “The Most Complex” Cancer Next PostIvy Brain Tumor Center makes giant step toward cancer treatment You Might Also Like TGen Receives Approval for Patient Enrollment in Brain Cancer Clinical Trial September 2, 2014 Ivy Foundation Project Kick-off Meeting Focuses on Collaboration January 23, 2009 Brain Tumor Patients Put on Fast Track in Revolutionary Clinical Trial March 10, 2015 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
